Skip to main content

Table 2 Summary comparison of measurement properties among ALSFRS-R and more recent qualitative measurement scales for functioning

From: Qualitative measures that assess functional disability and quality of life in ALS

 

ALSFRS-R

ALSFRS-EX

ALS-MITOSa

CNS-BFS

DALS-15

MND-DS

ROADS

Conceptual model

Construct defined

✓

✓

✓

✓

✓

✓

✓

Target population defined

✓

✓

✓

✓

✓

✓

✓

Expected subscales described

✓

✓

✓

n/a

n/a

n/a

n/a

Content validity

Patient Input

X

✓

a

✓

✓

✓

✓

Expert Input

✓

✓

✓

✓

✓

✓

✓

Description of item development (Item generation /reduction)

X

✓

a

✓

✓

✓

✓

Reliability

Test retest

✓

✓

a

✓

✓

✓

✓

Internal consistency

✓

✓

a

✓

✓

✓

✓

Construct validity

Convergent

✓

✓

✓

✓

✓

✓

✓

Longitudinal

✓

✓

✓

✓

In progress

TBD

In progress

Responsiveness

Across disease subgroups

✓

✓

✓

✓

✓

✓

✓

Functional status

✓

✓

✓

✓

✓

✓

✓

Therapy/treatment

✓

TBD

TBD

✓

In progress

TBD

In progress

Interpretation and scoring

Plan for scoring measure

✓

✓

✓

✓

✓

✓

✓

Scaling described

✓

✓

✓

✓

✓

✓

✓

Ease of use/patient burden

Easy to administer

✓

✓

✓

✓

✓

✓

✓

Length reasonable—minimal patient burden

✓

✓

✓

✓

✓

✓

✓

  1. TBD to be determined
  2. aStaging system developed as a novel way to interpret the scoring of the already validated ALSFRS-R domains. No item generation or reduction required. As such, no patient input sought. No additional clinical expert input sought